Data from 2 studies, LIGHTHOUSE and SPOTLIGHT, have shown the benefit of flotufolastat F 18 injection as a radiohybrid PSMA-targeted PET imaging agent in prostate cancer. The agent has now been added ...
A randomized phase III trial run out of the United Kingdom has found that estradiol skin patches suppress testosterone as ...
HRT-style patches may treat prostate cancer as effectively as injections, with fewer side effects and greater convenience.